Abstract
To supplement both the FDA and EMA guidance, we describe the principles and key elements for developing a DMC chart for individual clinical trials affected by COVID-19.
Original language | American English |
---|---|
Journal | |
State | Published - Apr 21 2020 |
DC Disciplines
- Biostatistics
- Environmental Public Health
- Epidemiology
- Public Health